Paid Clinical Trials in Boise, ID
As of August 2026, 212 paid clinical trials are recruiting in Boise, Idaho. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Boise offers studies at sites including Saint Luke's Cancer Institute - Boise for conditions such as Acute Myeloid Leukemia, ARDS, Acute Respiratory Distress Syndrome, Focal Epilepsy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Boise
Trials by drug in Boise
Filter results
Newly added in Boise
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.
Long-Term Outcomes Following HBOT
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
201 clinical trials
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
Top Research Study Locations in Boise
Researchers run research studies in Boise, ID at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Cancer Institute - Boise | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 79 |
| Saint Alphonsus Cancer Care Center-Boise | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 59 |
| St. Luke's Boise Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 6 |
| Treasure Valley Medical Research | Atopic Dermatitis, Chronic Idiopathic Constipation (CIC), Chronic Inducible Urticaria | 6 |
| Saint Alphonsus Regional Medical Center | Amyotrophic Lateral Sclerosis, Colonic Diseases, Colorectal Neoplasms | 4 |
| Advanced Specialty Research | Healthy, Idiopathic Overactive Bladder, Idiopathic Overactive Bladder With Urinary Incontinence | 3 |
| Boise VA Medical Center | Chronic Obstructive Pulmonary Disease, HIV, Inhaled Corticosteroid | 3 |
| Consultants in Epilepsy & Neurology, PLLC | Focal Epilepsy, Epilepsy, Focal Seizure | 3 |
| Consultants in Epilepsy and Neurology, PLLC | Epilepsy, Focal Epilepsy, Focal Onset Seizure | 3 |
| ASR, LLC | Pneumococcal Disease, Alopecia Areata | 3 |
| St. Luke's Cancer Institute: Boise | Carcinoma, Transitional Cell, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Neoplasm Metastasis | 3 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Boise VA Medical Center, Boise, ID | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Chronic Pain, Metastatic Castrate Resistant Prostate Cancer | 2 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 2 |
| Northwest Clinical Trials, Inc. | Actinic Keratosis, Migraine | 2 |
| Saint Alphonsus Regional Medical Center - Boise | Atrial Fibrillation, Intracerebral Hemorrhage, Non-small Cell Lung Cancer | 2 |
| Saint Luke's Cystic Fibrosis Center of Idaho | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| St. Alphonsus Regional Medical Center | Aortic Stenosis, Brain Tumor, Brain Tumor - Metastatic | 2 |
| St. Luke's Children's Endocrinology and Diabetes | Noonan Syndrome, Type 2 Diabetes | 2 |
| Summit Hyperbarics and Wellness | PTSD - Post Traumatic Stress Disorder, Post Concussive Syndrome, Post-Concussive Symptoms | 2 |
| Saint Alphonsus Regional Medical Center | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Colon Adenocarcinoma | 2 |
| ASR Idaho CGI | HPV, HPV - Anogenital Human Papilloma Virus Infection | 1 |
| Boise State University | Distress, Emotional | 1 |
| Boise, Idaho Investigative | Acute Heart Failure, Heart Failure | 1 |
| CARE Institute - Boise Kidney | Kidney Disease | 1 |
Active & Upcoming Studies in Boise (2026)
Recruiting trials in Boise grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (101 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Neurology & pain (11 active studies)
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 · Phase 3 · Rapport Therapeutics Inc.
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Cardiovascular (7 active studies)
- Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System · Boston Scientific Corporation
- A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF · Heart Rhythm Clinical and Research Solutions, LLC
Vaccines (5 active studies)
Diabetes & metabolic (5 active studies)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes · Phase 3 · Sanofi
Mental health & behavior (2 active studies)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
- Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy · Phase 2 · Summit Hyperbarics and Wellness
HIV / STI (1 active study)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
Common conditions studied in Boise
- Acute Myeloid Leukemia (8 active studies)
- ARDS (5 active studies)
- Acute Respiratory Distress Syndrome (5 active studies)
- Focal Epilepsy (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Stage IV Lung Cancer AJCC v8 (5 active studies)
Leading research sponsors in Boise
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Boise?
There are approximately 212 recruiting clinical trials in Boise, Idaho listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Boise pay participants?
Most recruiting trials in Boise compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Boise?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Boise?
The most common conditions under active study in Boise include Acute Myeloid Leukemia (8), ARDS (5), Acute Respiratory Distress Syndrome (5), Focal Epilepsy (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Boise?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Boise on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Boise?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Boise?
Recruiting research sites in Boise include Saint Luke's Cancer Institute - Boise, Saint Alphonsus Cancer Care Center-Boise, St. Luke's Boise Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Boise right now?
The largest active categories in Boise are Cancer & tumors (101), Neurology & pain (11), Cardiovascular (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.